Format

Send to

Choose Destination
See comment in PubMed Commons below
Biomed Res Int. 2013;2013:845816. doi: 10.1155/2013/845816. Epub 2013 Jan 31.

A new dual-promoter system for cardiomyocyte-specific conditional induction of apoptosis.

Author information

  • 1Gruppo Intini-SMA Laboratory of Experimental Cardiology, Institute of Life Sciences, Scuola Superiore Sant'Anna, 56127 Pisa, Italy.

Abstract

Apoptosis is a key determinant of major pathological processes, including chronic cardiac failure. We developed and tested in vitro a novel system to induce cardiomyocyte-specific apoptosis by virus-mediated delivery of a conditional transgene. The entire system was packaged in a lentiviral vector. We used the cardiomyocyte-specific Na(+)-Ca(2+) exchange promoter to control the transcription of the reverse tetracycline transactivator, while the transgene expression was driven by the tetracycline-responsive element. The proapoptotic transgene of choice was the short isoform of the apoptosis-inducing factor, known to quickly induce the caspase-independent apoptosis when overexpressed in cells. Transduction of cardiomyocyte cells with this vector caused a tetracycline-regulated induction of apoptosis, which was not observed in noncardiac cells. Therefore, our system proved a valuable molecular tool for inducing controlled apoptosis in selected cells. Furthermore, the vector we developed is suitable for "lentivirus transgenesis," an interesting strategy recently proposed for the genetic manipulation of animals other than mice, including large mammals.

PMID:
23573514
PMCID:
PMC3581143
DOI:
10.1155/2013/845816
[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Hindawi Publishing Corporation Icon for PubMed Central
    Loading ...
    Support Center